{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:01:32Z","timestamp":1792602092594,"version":"4.5.0"},"reference-count":36,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Peritoneal dissemination threatens the survival of patients with gastric cancer (GC). Bufalin is an extract of traditional Chinese medicine, which has been proved to have anticancer effect. The target of bufalin in suppressing gastric cancer peritoneal dissemination (GCPD) and the underlying mechanism are still unclear. In this research, GC cell line MGC\u2010803 and high\u2010potential peritoneal dissemination cell line MKN\u201045P were treated with bufalin or L\u2010NAME. Malignant biological behavior and protein level of GC cell lines were detected with MTT, wound healing, transwell, adhesion, and western blotting. Bioinformatics analysis and patient tissues were used to verify the role of endothelial nitric oxide synthase (NOS3) in GC. Mice model was used to assess the effect of bufalin and role of NOS3 in vivo. We found that bufalin inhibited the proliferation, invasion, and migration in GC cell lines. NOS3, which was an independent prognostic factor of GC patients, was predicted to be a potential target of bufalin. Further experiments proved that bufalin reduced the phosphorylation of NOS3, thereby inhibiting the mitogen\u2010activated protein kinase (MAPK) signaling pathway, and ultimately suppressed GCPD by inhibiting EMT process. In conclusion, NOS3 was a potential therapeutic target and prognostic biomarker of GC. Bufalin could suppress GCPD through NOS3\u2010MAPK signaling pathway, which provided more evidence support for intraperitoneal perfusion of bufalin to treat GCPD.<\/jats:p>","DOI":"10.1096\/fj.202002780r","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T05:09:52Z","timestamp":1619672992000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Bufalin inhibits peritoneal dissemination of gastric cancer through endothelial nitric oxide synthase\u2010mitogen\u2010activated protein kinases signaling pathway"],"prefix":"10.1096","volume":"35","author":[{"given":"Dan","family":"Zou","sequence":"first","affiliation":[{"name":"The First Laboratory of Cancer Institute, the First Hospital of China Medical University Shenyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincheng","family":"Song","sequence":"additional","affiliation":[{"name":"The First Laboratory of Cancer Institute, the First Hospital of China Medical University Shenyang China"},{"name":"Department of Oncology the Second Affiliated Hospital of Dalian Medical University Dalian China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Deng","sequence":"additional","affiliation":[{"name":"Graduate School of Peking Union Medical College Chinese Academy of Medical Sciences, Peking Union Medical College Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanju","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Cancer Hospital of China Medical University, Liaoning Cancer Hospital &amp; Insititute Shenyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjiao","family":"Yang","sequence":"additional","affiliation":[{"name":"The First Laboratory of Cancer Institute, the First Hospital of China Medical University Shenyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Laboratory of Cancer Institute, the First Hospital of China Medical University Shenyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wang","sequence":"additional","affiliation":[{"name":"The First Laboratory of Cancer Institute, the First Hospital of China Medical University Shenyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenpeng","family":"Wen","sequence":"additional","affiliation":[{"name":"The First Laboratory of Cancer Institute, the First Hospital of China Medical University Shenyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Cancer Hospital of China Medical University, Liaoning Cancer Hospital &amp; Insititute Shenyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology the First Hospital of China Medical University Shenyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[{"name":"The First Laboratory of Cancer Institute, the First Hospital of China Medical University Shenyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,4,29]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i30.6829"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-012-9351-2"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01703-x"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082236"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i41.6979"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-016-0660-y"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28373"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1142\/S0192415X19500125"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0806-1"},{"issue":"4","key":"e_1_2_9_11_1","first-page":"3635","article-title":"A research update on the anticancer effects of bufalin and its derivatives","volume":"17","author":"Lan YL","year":"2019","journal-title":"Oncol Lett"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-17-1296"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11076"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0b013e3283160fd6"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cr.7290133"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2149"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074464"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00109.2016"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.2739\/kurumemedj.58.73"},{"issue":"4","key":"e_1_2_9_20_1","first-page":"809","article-title":"Significance of integrin alpha2\/beta1 in peritoneal dissemination of a human gastric cancer xenograft model","volume":"18","author":"Kawamura T","year":"2001","journal-title":"Int J Oncol"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx374"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn923"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27521-y"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.7150\/jca.38393"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-019-0234-8"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2016.11.004"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2016.3667"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-017-2663-1"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2019.04.012"},{"issue":"15","key":"e_1_2_9_30_1","first-page":"3384","article-title":"Reduced miR\u2010490\u20103p expression is associated with poor prognosis of Helicobacter pylori induced gastric cancer","volume":"21","author":"Qu M","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.528695"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(02)00851-1"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-017-0472-5"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.7150\/jca.25581"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2019.01.005"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-012-1131-x"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2019.05.004"}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.202002780R","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fj.202002780R","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.202002780R","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:03:26Z","timestamp":1761674606000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fj.202002780R"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,29]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["10.1096\/fj.202002780R"],"URL":"https:\/\/doi.org\/10.1096\/fj.202002780r","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,29]]},"assertion":[{"value":"2020-12-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e21601"}}